Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kati Sarnola"'
Publikováno v:
BMJ Open, Vol 14, Iss 10 (2024)
Introduction During the last decade, extensions of therapeutic indications have been one of the most common methods to extend the lifecycle of a medical product in the post-authorisation phase and to increase the use and sales of medicines. The aim o
Externí odkaz:
https://doaj.org/article/a6772af1e1ef441aa2d591e6e417df9c
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Nordic countries excel in cancer care, but studies on uptake, costs, or managed entry agreements of cancer medicines have not been conducted recently. The aim of this study was to examine the uptake and availability of orally admi
Externí odkaz:
https://doaj.org/article/90c163f1fa2a4eb996a6771615bdef9a
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Introduction: Product life cycle refers to all phases of a product from development to active market phase and finally the phase in which products possibly exit the market. The product life cycle of medicines in short supply has not been studied in d
Externí odkaz:
https://doaj.org/article/f4eb8e6e405d408bad08656cd6ec756d
Autor:
Isabelle Arnet, Melina Verbeek, Birna Almarsdóttir Anna, Liese Barbier, Rhonda Clifford, Christiane Eickhoff, Kurt Hersberger, Isabelle Huys, Kenny Lee, Kritsanee Saramunee, Martin Schulz, David Zgarrick, Kati Sarnola
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 4, Iss , Pp 100084- (2021)
Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert ro
Externí odkaz:
https://doaj.org/article/60395ed6f9cd467db5386e97aee9c018
Publikováno v:
BMJ Open, Vol 10, Iss 5 (2020)
Objectives To examine physicians’ perceptions of the uptake of biosimilars.Design Systematic review.Data sources MedLine Ovid and Scopus databases at the end of 2018.Eligibility criteria Original scientific studies written in English that addressed
Externí odkaz:
https://doaj.org/article/61ac0047f7ff45fd952c55de8683973c
Autor:
Liese Barbier, Christiane Eickhoff, Isabelle Huys, Isabelle Arnet, Kurt E. Hersberger, Martin Schulz, Kenny Lee, Melina Verbeek, Rhonda Clifford, Birna Almarsdóttir Anna, Kati Sarnola, David P. Zgarrick, Kritsanee Saramunee
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 4, Iss, Pp 100084-(2021)
Arnet, I, Verbeek, M, Almarsdóttir, A B, Barbier, L, Clifford, R, Eickhoff, C, Hersberger, K, Huys, I, Lee, K, Saramunee, K, Schulz, M, Zgarrick, D & Sarnola, K 2021, ' Community pharmacists' preparedness for substituting biologics and dispensing biosimilars : Lessons learned from a multinational survey ', Exploratory Research in Clinical and Social Pharmacy, vol. 4, 100084 . https://doi.org/10.1016/j.rcsop.2021.100084
Arnet, I, Verbeek, M, Almarsdóttir, A B, Barbier, L, Clifford, R, Eickhoff, C, Hersberger, K, Huys, I, Lee, K, Saramunee, K, Schulz, M, Zgarrick, D & Sarnola, K 2021, ' Community pharmacists' preparedness for substituting biologics and dispensing biosimilars : Lessons learned from a multinational survey ', Exploratory Research in Clinical and Social Pharmacy, vol. 4, 100084 . https://doi.org/10.1016/j.rcsop.2021.100084
Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df783aea99a6d0b25895609c6f3c6022
https://pubmed.ncbi.nlm.nih.gov/35479848
https://pubmed.ncbi.nlm.nih.gov/35479848
Autor:
Johanna Linnolahti, Kati Sarnola
Publikováno v:
International Journal of Clinical Pharmacy
The good availability of medicines and medicine shortages have become global issues during recent years. Medicine shortages are often affected by universal determinants, but the availability of medicines is also depending on national characteristics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09cf80d10e7f9a039fd351fbb2249bc2
https://pubmed.ncbi.nlm.nih.gov/31172411
https://pubmed.ncbi.nlm.nih.gov/31172411
Publikováno v:
European journal of clinical pharmacology. 74(7)
To assess pricing and reimbursement policies specific to orphan medicines and the availability and distribution settings of ten recently authorised medicinal products suitable for outpatient care with orphan status and centralised marketing authorisa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6465e4f348cd8fbc7152f6915dded71
https://pubmed.ncbi.nlm.nih.gov/29632962
https://pubmed.ncbi.nlm.nih.gov/29632962